Personal Perspective: MDS Patient Gets Involved With Advocacy And Raising … – The MDS Beacon
Personal Perspective: MDS Patient Gets Involved With Advocacy And Raising ... The MDS Beacon They learned that day that the only known cure for MDS is a donor (allogeneic) stem cell transplant. They decided then and there that Jack would have a transplant as soon as he was determined to be a viable candidate. Immediately after diagnosis ... |
Organ donation law soon: Minister – The Hindu
Organ donation law soon: Minister The Hindu The State is contemplating a human organ donation and transplantation law on the lines of the one enacted by Tamil Nadu, Health Minister Adoor Prakash told the Assembly on Wednesday. Replying to a submission by MP Vincent (Congress), ... |
Chronic Kidney Disease (CKD) Therapeutics – Pipeline Assessment and Market … – NEWS.GNOM.ES (press release)
Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market ... NEWS.GNOM.ES (press release) ES/ — Reportlinker.com announces that a new market research report is available in its catalogue: GlobalData, the industry analysis specialist, has released its new report, “Chronic Kidney Disease (CKD) Therapeutics – Pipeline Assessment and Market ... Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market ... |
Rabbis urge religious public to volunteer as organ donors – Sun-Sentinel
Rabbis urge religious public to volunteer as organ donors Sun-Sentinel Brain death was established by the most respected arbiter of Jewish law of recent times, Rabbi Moshe Feinstein, to be the relevant criterion for declaring death, although he stipulated that tests be conducted to confirm. ... |
Drug combo prolongs breast cancer survival time – Times of India
 The Oncology Report | Drug combo prolongs breast cancer survival time Times of India Everolimus is an established treatment for recurrent, advanced kidney cancer and researchers are now looking at its use in other cancers. The study found that women treated with a combination of everolimus and exemestane had an improved ... Novartis's Afinitor shows promise in breast cancer Afinitor (Everolimus) Prolongs Advanced Breast Cancer Patients' Progression ... Everolimus, exemestane improved outcomes in HT-resistant breast cancer |
Child brain tumour drug launched – The Press Association
 MedIndia | Child brain tumour drug launched The Press Association NHS doctors will be able to apply for funding from health trusts for Votubia (everolimus) for children with growing non-malignant brain tumours associated with a condition called tuberous sclerosis complex (TSC). The once-a-day pill offers an ... Drug that can shrink kids' brain tumours by 50% launched NHS to Offer Drug for Tuberous Sclerosis Complex Breakthrough Drug Launched, Would Shrivel Brain Tumors in Children by 50% |
Everolimus, exemestane improved outcomes in HT-resistant breast cancer – HemOncToday
 msnbc.com | Everolimus, exemestane improved outcomes in HT-resistant breast cancer HemOncToday Combining everolimus and exemestane improved PFS among postmenopausal women with advanced breast cancer resistant to hormonal therapy, according to data from a phase 3 trial. Results of the BOLERO-2 trial were presented at the 2011 European ... 'Strongest Ever Data' in Breast Cancer With Everolimus Afinitor (Everolimus) Prolongs Advanced Breast Cancer Patients' Progression ... Novartis drug Afinitor® helps women with advanced breast cancer live ... |
Robotic-assisted laparoscopic partial nephrectomy for a 7-cm mass in a renal … – UroToday
Robotic-assisted laparoscopic partial nephrectomy for a 7-cm mass in a renal ... UroToday Warm ischemia time (WIT) was 26.5 min. Estimated blood loss was 100 mL. There was no change between pre- and postoperative eGFR. There were no operative complications. Histology was papillary renal cell carcinoma type 1, nuclear grade 2. ... |
StemCells reports world’s 1st neural stem cell transplant in spinal cord … – pharmabiz.com
StemCells reports world's 1st neural stem cell transplant in spinal cord ... pharmabiz.com StemCells, Inc. announced that the first patient in the company's breakthrough phase I/II clinical trial in chronic spinal cord injury was successfully transplanted with the company's proprietary HuCNS-SC adult neural stem cells. ... |
Rabbis urge religious public to volunteer as organ donors – Jerusalem Post
Rabbis urge religious public to volunteer as organ donors Jerusalem Post Brain death was established by the most respected arbiter of Jewish law of recent times, Rabbi Moshe Feinstein, to be the relevant criterion for declaring death, although he stipulated that tests be conducted to confirm. ... |